Literature DB >> 28899226

Adenoid cystic carcinoma of the head and neck: a retrospective multicenter study.

Shinji Takebayashi1, Shogo Shinohara1, Hisanobu Tamaki2, Ichiro Tateya3, Morimasa Kitamura3, Masanobu Mizuta3, Shinzo Tanaka4, Tsuyoshi Kojima5, Ryo Asato6, Toshiki Maetani7, Koji Ushiro8, Yoshiharu Kitani9, Kazuyuki Ichimaru10, Keigo Honda11, Koichiro Yamada11, Koichi Omori3.   

Abstract

BACKGROUND: Adenoid cystic carcinoma of the head and neck (ACCHN) is rare and difficult to study effective treatment at one institute. Our aim is to identify prognostic factors for this disease by conducting a multicenter study at 11 institutions in Japan.
METHODS: A retrospective multicenter study of ACCHN was performed. One hundred and three patients were identified between 2006 and 2015. The overall survival (OS) rate for all patients was calculated, and OS, locoregional control (LRC) rate, or no distant metastasis (NDM) rate was calculated for patients in that the surgery was performed without distant metastasis (DM). Statistical analyses were performed.
RESULTS: A significant difference with multivariate analysis was observed in patients in sublingual glands, stage IV and the use of radiation therapy ≥60Gy (sufficient RT) in OS for all patients. A significant difference was observed in the use of sufficient postoperative RT in the OS and the LRC rate, and in pathological surgical margins in the NDM rate.
CONCLUSION: Sublingual glands or stage IV was a poorer, and sufficient RT was a better prognostic factor for ACCHN. Sufficient RT was effective to prevent local recurrence after surgical resection. Positive surgical margins caused an increase in DM.

Entities:  

Keywords:  Adenoid cystic carcinoma; dose of radiation therapy; head and neck; multicenter study

Mesh:

Substances:

Year:  2017        PMID: 28899226     DOI: 10.1080/00016489.2017.1371329

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  12 in total

1.  Evaluation of Multimodality Management of Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Amit Bahl; Naresh Kumar Panda; Arun Elangovan; Jaimanti Bakshi; Roshan Verma; Satyawati Mohindra; Rijuneeta Gupta; Arun Singh Oinam; Satinder Kaur; R K Vashishta; Sushmita Ghoshal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-07-07

2.  Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery.

Authors:  In Seong Jeong; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-06       Impact factor: 4.553

3.  Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up.

Authors:  Eiichi Ishida; Takenori Ogawa; Masahiro Rokugo; Tomohiko Ishikawa; Shun Wakamori; Akira Ohkoshi; Hajime Usubuchi; Kenjiro Higashi; Ryo Ishii; Ayako Nakanome; Yukio Katori
Journal:  Head Face Med       Date:  2020-07-02       Impact factor: 2.151

4.  Outcome of Adenoid Cystic Carcinoma of Head and Neck After Postoperative Intensity Modulation Radiotherapy: A Single Institution Study.

Authors:  Peng Xu; Shuo Wang; Yukun Luo; Jun Yin; Yazid Belkacemi; Shun Lu; Mei Feng; Jinyi Lang
Journal:  Cancer Manag Res       Date:  2021-03-15       Impact factor: 3.989

5.  Exploration of High-Grade Transformation and Postoperative Radiotherapy on Prognostic Analysis for Primary Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Yuelu Zhu; Xinyi Zhu; Xuemin Xue; Ye Zhang; Chunfang Hu; Wenchao Liu; Haizhen Lu
Journal:  Front Oncol       Date:  2021-04-09       Impact factor: 6.244

6.  The efficacy of iodine-125 interstitial brachytherapy for the treatment of locally advanced adenoid cystic carcinoma of the base of tongue: a non-surgical approach.

Authors:  Shuang Dong; Wei Li; Yan Shi; Xiao-Ming Lv; Ming-Wei Huang; Jian-Guo Zhang
Journal:  J Contemp Brachytherapy       Date:  2021-08-24

7.  Prognostic Factors and Survival in Adenoid Cystic Carcinoma of the Head and Neck: A Retrospective Clinical and Histopathological Analysis of Patients Seen at a Cancer Center.

Authors:  Everton Freitas de Morais; Leorik Pereira da Silva; Deborah Gondim Lambert Moreira; Rodrigo Porpino Mafra; Larissa Santos Amaral Rolim; Edilmar de Moura Santos; Lélia Batista de Souza; Roseana de Almeida Freitas
Journal:  Head Neck Pathol       Date:  2020-08-10

8.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11

9.  Trophoblast Cell Surface Antigen 2 (Trop-2) Protein is Highly Expressed in Salivary Gland Carcinomas and Represents a Potential Therapeutic Target.

Authors:  Philipp Wolber; Lisa Nachtsheim; Franziska Hoffmann; Jens Peter Klußmann; Moritz Meyer; Ferdinand von Eggeling; Orlando Guntinas-Lichius; Alexander Quaas; Christoph Arolt
Journal:  Head Neck Pathol       Date:  2021-04-22

10.  Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Johannes Doescher; Moritz Meyer; Christoph Arolt; Alexander Quaas; Jens Peter Klußmann; Philipp Wolber; Agnes Bankfalvi; Hans-Ulrich Schildhaus; Tobias Bastian; Stephan Lang; Simon Laban; Patrick J Schuler; Cornelia Brunner; Thomas K Hoffmann; Stephanie E Weissinger
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.